Fuzeon wins international innovation award but Roche concerned about uptake

摘要

Fuzeon (enfuvirtide) has been recognised by the award of the 2004 International Prix Galien to Roche,its manufacturer,for the most innovative new medicine.The company,which shared the UK Prix Galien with Wyeth earlier this year (PJ,2 October,p454),said that innovation was only one milestone of Fuzeon's success."The next crucial step is getting the drug to those who need it."